Cargando…
Inactivation of Heparin by Cationically Modified Chitosan
This study was performed to evaluate the ability of N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride (HTCC), the cationically modified chitosan, to form biologically inactive complexes with unfractionated heparin and thereby blocking its anticoagulant activity. Experiments were carried out...
Autores principales: | Lorkowska-Zawicka, Barbara, Kamiński, Kamil, Ciejka, Justyna, Szczubiałka, Krzysztof, Białas, Magdalena, Okoń, Krzysztof, Adamek, Dariusz, Nowakowska, Maria, Jawień, Jacek, Olszanecki, Rafał, Korbut, Ryszard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113808/ https://www.ncbi.nlm.nih.gov/pubmed/24983639 http://dx.doi.org/10.3390/md12073953 |
Ejemplares similares
-
Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin
por: Kalaska, Bartlomiej, et al.
Publicado: (2015) -
Synthetic sulfonated derivatives of poly(allylamine hydrochloride) as inhibitors of human metapneumovirus
por: Ciejka, Justyna, et al.
Publicado: (2019) -
Biopolymeric nano/microspheres for selective and reversible adsorption of coronaviruses
por: Ciejka, Justyna, et al.
Publicado: (2017) -
HTCC: Broad Range Inhibitor of Coronavirus Entry
por: Milewska, Aleksandra, et al.
Publicado: (2016) -
Mitochondrial Aldehyde Dehydrogenase Activation by Alda‐1 Inhibits Atherosclerosis and Attenuates Hepatic Steatosis in Apolipoprotein E‐Knockout Mice
por: Stachowicz, Aneta, et al.
Publicado: (2014)